Clinical Trial Update: JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating bevacizumab for Acute Respiratory Distress Syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: PPD Development, LP | Conditions: Acute Respiratory Distress Syndrome (ARDS), ARDS | Phase 2 | Status: RECRUITING